GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Parexel International Corporation (PRXL) [hlAlert]

Rating:
Buy PRXL
up 123.94 %

Parexel International Corporation (PRXL) rated Buy by Citigroup

Posted on: Tuesday,  Feb 18, 2014  8:25 AM ET by Citigroup

Citigroup rated Buy Parexel International Corporation (NASDAQ: PRXL) on 02/18/2014. Previously Citigroup rated Buy Parexel International Corporation (NASDAQ: PRXL) on 01/02/2013.,
when the stock price was $30.91. Since then, Parexel International Corporation has gained 123.94% as of 01/25/2016's recent price of $69.22.
If you would have followed the previous Citigroup's recommendation on PRXL, you would have gained 123.94% of your investment in 1118 days.

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/18/2014 8:25 AM Buy
None
52.44
as of 10/17/2014
1 Week up  1.80 %
1 Month down  -3.95 %
3 Months up  11.64 %
1 YTD up  31.11 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/2/2013 8:25 AM Buy
None
30.91

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy